Skip to main content
construction release_alert
The Scholars Team is working with OIT to resolve some issues with the Scholars search index
cancel
Journal cover image

A Rapid Host Response Blood Test for Bacterial/Viral Infection Discrimination Using a Portable Molecular Diagnostic Platform.

Publication ,  Journal Article
Iglesias-Ussel, MD; O'Grady, N; Anderson, J; Mitsis, PG; Burke, TW; Henao, R; Scavetta, J; Camilleri, C; Naderi, S; Carittini, A; Perelman, M ...
Published in: Open Forum Infect Dis
January 2025

BACKGROUND: Difficulty discriminating bacterial versus viral etiologies of infection drives unwarranted antibacterial prescriptions and, therefore, antibacterial resistance. METHODS: Utilizing a rapid portable test that measures peripheral blood host gene expression to discriminate bacterial and viral etiologies of infection (the HR-B/V assay on Biomeme's polymerase chain reaction-based Franklin platform), we tested 3 cohorts of subjects with suspected infection: the HR-B/V training cohort, the HR-B/V technical correlation cohort, and a coronavirus disease 2019 cohort. RESULTS: The Biomeme HR-B/V test showed very good performance at discriminating bacterial and viral infections, with a bacterial model accuracy of 84.5% (95% confidence interval [CI], 80.8%-87.5%), positive percent agreement (PPA) of 88.5% (95% CI, 81.3%-93.2%), negative percent agreement (NPA) of 83.1% (95% CI, 78.7%-86.7%), positive predictive value of 64.1% (95% CI, 56.3%-71.2%), and negative predictive value of 95.5% (95% CI, 92.4%-97.3%). The test showed excellent agreement with a previously developed BioFire HR-B/V test, with 100% (95% CI, 85.7%-100.0%) PPA and 94.9% (95% CI, 86.1%-98.3%) NPA for bacterial infection, and 100% (95% CI, 93.9%-100.0%) PPA and 100% (95% CI, 85.7%-100.0%) NPA for viral infection. Among subjects with acute severe acute respiratory syndrome coronavirus 2 infection of ≤7 days, accuracy was 93.3% (95% CI, 78.7%-98.2%) for 30 outpatients and 75.9% (95% CI, 57.9%-87.8%) for 29 inpatients. CONCLUSIONS: The Biomeme HR-B/V test is a rapid, portable test with high performance at identifying patients unlikely to have bacterial infection, offering a promising antibiotic stewardship strategy that could be deployed as a portable, laboratory-based test.

Duke Scholars

Published In

Open Forum Infect Dis

DOI

ISSN

2328-8957

Publication Date

January 2025

Volume

12

Issue

1

Start / End Page

ofae729

Location

United States

Related Subject Headings

  • 3207 Medical microbiology
  • 3202 Clinical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Iglesias-Ussel, M. D., O’Grady, N., Anderson, J., Mitsis, P. G., Burke, T. W., Henao, R., … Woods, C. W. (2025). A Rapid Host Response Blood Test for Bacterial/Viral Infection Discrimination Using a Portable Molecular Diagnostic Platform. Open Forum Infect Dis, 12(1), ofae729. https://doi.org/10.1093/ofid/ofae729
Iglesias-Ussel, Maria D., Nicholas O’Grady, Jack Anderson, Paul G. Mitsis, Thomas W. Burke, Ricardo Henao, Joseph Scavetta, et al. “A Rapid Host Response Blood Test for Bacterial/Viral Infection Discrimination Using a Portable Molecular Diagnostic Platform.Open Forum Infect Dis 12, no. 1 (January 2025): ofae729. https://doi.org/10.1093/ofid/ofae729.
Iglesias-Ussel MD, O’Grady N, Anderson J, Mitsis PG, Burke TW, Henao R, et al. A Rapid Host Response Blood Test for Bacterial/Viral Infection Discrimination Using a Portable Molecular Diagnostic Platform. Open Forum Infect Dis. 2025 Jan;12(1):ofae729.
Iglesias-Ussel, Maria D., et al. “A Rapid Host Response Blood Test for Bacterial/Viral Infection Discrimination Using a Portable Molecular Diagnostic Platform.Open Forum Infect Dis, vol. 12, no. 1, Jan. 2025, p. ofae729. Pubmed, doi:10.1093/ofid/ofae729.
Iglesias-Ussel MD, O’Grady N, Anderson J, Mitsis PG, Burke TW, Henao R, Scavetta J, Camilleri C, Naderi S, Carittini A, Perelman M, Myers RA, Ginsburg GS, Ko ER, McClain MT, van Westrienen J, Tsalik EL, Tillekeratne LG, Woods CW. A Rapid Host Response Blood Test for Bacterial/Viral Infection Discrimination Using a Portable Molecular Diagnostic Platform. Open Forum Infect Dis. 2025 Jan;12(1):ofae729.
Journal cover image

Published In

Open Forum Infect Dis

DOI

ISSN

2328-8957

Publication Date

January 2025

Volume

12

Issue

1

Start / End Page

ofae729

Location

United States

Related Subject Headings

  • 3207 Medical microbiology
  • 3202 Clinical sciences